SPOTLIGHT -
EP. 1: Classification of Ovarian Cancers
EP. 2: BRCA Testing for Ovarian Cancer
EP. 3: When to Refer to Genetic Counseling
EP. 4: Surgical Management of Advanced Ovarian Cancer
EP. 5: Intravenous vs Intraperitoneal Chemotherapy for Ovarian Cancer
EP. 6: Dose-Dense Chemotherapy for Ovarian Cancer; Adding Bevacizumab
EP. 7: Recurrent Ovarian Cancer; Considerations Beyond the Platinum-Free Interval
EP. 8: Bevacizumab for Recurrent Ovarian Cancer
EP. 9: PARP Inhibitors for Ovarian Cancer: Use of Olaparib
EP. 10: Rucaparib for Ovarian Cancer
EP. 11: Niraparib Maintenance Therapy for Ovarian Cancer
EP. 12: Sequencing Therapies for Ovarian Cancer
EP. 13: Differences Among PARP Inhibitors in Ovarian Cancer
EP. 14: Ongoing PARP Inhibitor Research in Ovarian Cancer
EP. 15: Future Directions for Treating Advanced Ovarian Cancers
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
